PharmaCoNets of Mesoridazine (SPCN: 75.49 )

Drug NamePathway IDPathway nameP-valueNo. of gene membersUniProt ACGene nameDetail of Coexpression
Mesoridazinehsa00030Pentose phosphate pathway3.06E-043P60891, P51854, P37837PRPS1, TKTL1, TALDO1More
Mesoridazinehsa00040Pentose and glucuronate interconversions4.00E-021P15121AKR1B1More
Mesoridazinehsa00190Oxidative phosphorylation2.29E-022Q16718, O14521NDUFA5, SDHDMore
Mesoridazinehsa00500Starch and sucrose metabolism2.21E-023O43451, P46976, P06737MGAM, GYG1, PYGLMore
Mesoridazinehsa00520Amino sugar and nucleotide sugar metabolism2.24E-023Q16222, Q9Y223, P06865UAP1, GNE, HEXAMore
Mesoridazinehsa00590Arachidonic acid metabolism3.85E-022P11712, P09960CYP2C9, LTA4HMore
Mesoridazinehsa00591Linoleic acid metabolism4.07E-021P11712CYP2C9More
Mesoridazinehsa00600Sphingolipid metabolism4.77E-023Q9BX95, O14494, P06280SGPP1, PLPP1, GLAMore
Mesoridazinehsa00620Pyruvate metabolism3.90E-022P07195, P11766LDHB, ADH5More
Mesoridazinehsa00770Pantothenate and CoA biosynthesis1.15E-022O95498, Q9NRN7VNN2, AASDHPPTMore
Mesoridazinehsa00790Folate biosynthesis2.02E-021P15121AKR1B1More
Mesoridazinehsa00970Aminoacyl-tRNA biosynthesis2.12E-021P14868DARSMore
Mesoridazinehsa00980Metabolism of xenobiotics by cytochrome P4506.38E-043P78417, P09211, P11712GSTO1, GSTP1, CYP2C9More
Mesoridazinehsa00982Drug metabolism - cytochrome P4509.14E-032P11712, P78417CYP2C9, GSTO1More
Mesoridazinehsa00983Drug metabolism - other enzymes3.48E-033P04183, P32320, P05164TK1, CDA, MPOMore
Mesoridazinehsa01200Carbon metabolism4.32E-023P51854, P37837, P60891TKTL1, TALDO1, PRPS1More
Mesoridazinehsa01230Biosynthesis of amino acids2.92E-035P51854, P60891, P05089, P15104, P37837TKTL1, PRPS1, ARG1, GLUL, TALDO1More
Mesoridazinehsa01240Biosynthesis of cofactors2.52E-022Q9BQB6, P14550VKORC1, AKR1A1More
Mesoridazinehsa01524Platinum drug resistance1.79E-022O15392, P11388BIRC5, TOP2AMore
Mesoridazinehsa02010ABC transporters2.29E-022P45844, P08183ABCG1, ABCB1More
Mesoridazinehsa03010Ribosome2.25E-045P40429, Q07020, P27635, P05386, P62249RPL13A, RPL18, RPL10, RPLP1, RPS16More
Mesoridazinehsa03013RNA transport2.12E-029P52298, O14893, P61326, Q7Z3B4, P35658, Q14152, O75822, P78345, Q9Y6A5NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3A, EIF3J, RPP38, TACC3More
Mesoridazinehsa03018RNA degradation5.00E-021Q9NQT4EXOSC5More
Mesoridazinehsa03022Basal transcription factors3.32E-022O00268, Q15544TAF4, TAF11More
Mesoridazinehsa03060Protein export4.46E-032Q15070, O76094OXA1L, SRP72More
Mesoridazinehsa03320PPAR signaling pathway4.33E-022Q6PCB7, Q9UNU6SLC27A1, CYP8B1More
Mesoridazinehsa03410Base excision repair2.52E-022P49005, P29372POLD2, MPGMore
Mesoridazinehsa03450Non-homologous end-joining4.21E-021P13010XRCC5More
Mesoridazinehsa04060Cytokine-cytokine receptor interaction2.05E-0211P27930, P14778, P26842, Q13651, P25024, P25025, Q9UBD3, P47992, P09341, P18510, P01730IL1R2, IL1R1, CD27, IL10RA, CXCR1, CXCR2, XCL2, XCL1, CXCL1, IL1RN, CD4More
Mesoridazinehsa04061Viral protein interaction with cytokine and cytokine receptor3.68E-038P09341, P19875, P25024, P25025, P47992, Q9UBD3, Q13651, P14784CXCL1, CXCL2, CXCR1, CXCR2, XCL1, XCL2, IL10RA, IL2RBMore
Mesoridazinehsa04062Chemokine signaling pathway4.11E-0413P25024, P25025, P09341, P19875, P47992, Q9UBD3, P07948, P42338, P19174, P63218, P50151, Q08881, P49841CXCR1, CXCR2, CXCL1, CXCL2, XCL1, XCL2, LYN, PIK3CB, PLCG1, GNG5, GNG10, ITK, GSK3BMore
Mesoridazinehsa04064NF-kappa B signaling pathway7.48E-0514P10415, O00463, P14778, P19174, Q04759, Q9UDY8, Q16548, P07948, P06239, Q13315, P24522, P09341, P19875, Q06643BCL2, TRAF5, IL1R1, PLCG1, PRKCQ, MALT1, BCL2A1, LYN, LCK, ATM, GADD45A, CXCL1, CXCL2, LTBMore
Mesoridazinehsa04071Sphingolipid signaling pathway1.82E-047P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, P10415PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2More
Mesoridazinehsa04072Phospholipase D signaling pathway4.48E-025P42338, P43657, P25024, P25025, P19174PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1More
Mesoridazinehsa04080Neuroactive ligand-receptor interaction2.16E-039P08311, P28472, Q15722, P21453, Q9H228, O00398, P21730, Q16581, P07550CTSG, GABRB3, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, C3AR1, ADRB2More
Mesoridazinehsa04114Oocyte meiosis6.23E-035Q9Y6D9, P51812, Q02750, P16298, Q17RY0MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4More
Mesoridazinehsa04115p53 signaling pathway3.98E-025P24522, Q13315, Q53FA7, O95067, P10415GADD45A, ATM, TP53I3, CCNB2, BCL2More
Mesoridazinehsa04120Ubiquitin mediated proteolysis3.44E-024Q14145, Q13042, P62837, Q15751KEAP1, CDC16, UBE2D2, HERC1More
Mesoridazinehsa04145Phagosome3.82E-038Q15080, P14598, Q13509, P68371, Q13488, P05164, O60603, P35443NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, MPO, TLR2, THBS4More
Mesoridazinehsa04210Apoptosis3.77E-028Q13315, P10415, O76075, P24522, Q16548, P43234, P18848, Q14643ATM, BCL2, DFFB, GADD45A, BCL2A1, CTSO, ATF4, ITPR1More
Mesoridazinehsa04213Longevity regulating pathway - multiple species3.85E-024P42338, Q9Y4H2, P11142, Q13547PIK3CB, IRS2, HSPA8, HDAC1More
Mesoridazinehsa04217Necroptosis2.34E-024P01375, P48023, Q14765, Q99878TNF, FASLG, STAT4, H2AC14More
Mesoridazinehsa04261Adrenergic signaling in cardiomyocytes2.95E-024P07550, P22694, P18848, Q13362ADRB2, PRKACB, ATF4, PPP2R5CMore
Mesoridazinehsa04370VEGF signaling pathway3.06E-033P16298, Q05397, Q02750PPP3CB, PTK2, MAP2K1More
Mesoridazinehsa04530Tight junction3.29E-023P16989, P56750, Q14247CSDA, CLDN17, CTTNMore
Mesoridazinehsa04610Complement and coagulation cascades1.47E-052P00734, P0C0L4F2, C4AMore
Mesoridazinehsa04612Antigen processing and presentation2.09E-048P13765, P48382, Q14953, P26715, P26717, Q13241, P01732, P01375HLA-DOB, RFX5, KIR2DS5, KLRC1, KLRC2, KLRD1, CD8A, TNFMore
Mesoridazinehsa04613Neutrophil extracellular trap formation2.18E-037P04908, Q93077, P62807, O60814, P68431, O43315, Q16539H2AC4; H2AC8, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, AQP9, MAPK14More
Mesoridazinehsa04640Hematopoietic cell lineage1.48E-0412P13612, P14778, P27930, P11215, P11836, P25063, P07766, P09693, P01732, P01730, P09564, P13765ITGA4, IL1R1, IL1R2, ITGAM, MS4A1, CD24, CD3E, CD3G, CD8A, CD4, CD7, HLA-DOBMore
Mesoridazinehsa04650Natural killer cell mediated cytotoxicity9.30E-0817P16298, P50591, P19174, P01375, P78314, P06239, O60880, P20963, P42338, Q02750, Q13241, P26718, O14931, O75015, P26717, Q14953, P26715PPP3CB, TNFSF10, PLCG1, TNF, SH3BP2, LCK, SH2D1A, CD247, PIK3CB, MAP2K1, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KIR2DS5, KLRC1More
Mesoridazinehsa04657IL-17 signaling pathway2.41E-024P19875, P14780, P80188, P01375CXCL2, MMP9, LCN2, TNFMore
Mesoridazinehsa04658Th1 and Th2 cell differentiation1.52E-0913Q04759, P07766, P20963, P09693, Q16539, P19174, P01730, P06239, P23771, Q9UL17, P14784, P13765, Q13761PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, CD4, LCK, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3More
Mesoridazinehsa04659Th17 cell differentiation1.42E-0713Q04759, Q16539, P19174, P01730, P06239, P14784, P13765, P14778, Q9UL17, P23771, P07766, P09693, P20963PRKCQ, MAPK14, PLCG1, CD4, LCK, IL2RB, HLA-DOB, IL1R1, TBX21, GATA3, CD3E, CD3G, CD247More
Mesoridazinehsa04660T cell receptor signaling pathway3.47E-0714Q04759, P42338, O95267, Q08881, P19174, P07766, P20963, P09693, P01730, P01732, Q13191, P06239, Q16539, P49841PRKCQ, PIK3CB, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD4, CD8A, CBLB, LCK, MAPK14, GSK3BMore
Mesoridazinehsa04662B cell receptor signaling pathway2.57E-025P49841, P60033, P07948, P21854, Q8N149GSK3B, CD81, LYN, CD72, LILRA2More
Mesoridazinehsa04668TNF signaling pathway3.55E-024P01375, P18848, P19875, P14780TNF, ATF4, CXCL2, MMP9More
Mesoridazinehsa04714Thermogenesis5.21E-034Q16539, P33121, Q16718, O14521MAPK14, ACSL1, NDUFA5, SDHDMore
Mesoridazinehsa04720Long-term potentiation2.85E-023P16298, P51812, Q02750PPP3CB, RPS6KA3, MAP2K1More
Mesoridazinehsa04722Neurotrophin signaling pathway3.27E-023P49841, O43524, P48023GSK3B, FOXO3, FASLGMore
Mesoridazinehsa04725Cholinergic synapse4.83E-024P22694, Q14643, P18848, P10415PRKACB, ITPR1, ATF4, BCL2More
Mesoridazinehsa04740Olfactory transduction2.52E-021Q9H255OR51E2More
Mesoridazinehsa04742Taste transduction1.01E-021P30939HTR1FMore
Mesoridazinehsa04750Inflammatory mediator regulation of TRP channels7.24E-035P14778, P19174, P42338, P24723, Q04759IL1R1, PLCG1, PIK3CB, PRKCH, PRKCQMore
Mesoridazinehsa04913Ovarian steroidogenesis2.54E-022P42330, P22694AKR1C3, PRKACBMore
Mesoridazinehsa04914Progesterone-mediated oocyte maturation1.00E-024Q17RY0, Q9Y6D9, P51812, Q02750CPEB4, MAD1L1, RPS6KA3, MAP2K1More
Mesoridazinehsa04915Estrogen signaling pathway2.96E-025P14780, P22694, P18848, Q14643, P10415MMP9, PRKACB, ATF4, ITPR1, BCL2More
Mesoridazinehsa04918Thyroid hormone synthesis3.50E-023P22694, P18848, Q14643PRKACB, ATF4, ITPR1More
Mesoridazinehsa04923Regulation of lipolysis in adipocytes2.24E-023P07550, P42338, Q9Y4H2ADRB2, PIK3CB, IRS2More
Mesoridazinehsa04924Renin secretion4.04E-022P22694, P07550PRKACB, ADRB2More
Mesoridazinehsa04926Relaxin signaling pathway2.41E-024P18848, P22694, P14780, P30679ATF4, PRKACB, MMP9, GNA15More
Mesoridazinehsa04927Cortisol synthesis and secretion4.44E-043Q14643, P18848, P22694ITPR1, ATF4, PRKACBMore
Mesoridazinehsa04928Parathyroid hormone synthesis, secretion and action2.13E-025Q14643, P22694, P23771, P18848, P10415ITPR1, PRKACB, GATA3, ATF4, BCL2More
Mesoridazinehsa04932Non-alcoholic fatty liver disease2.44E-035P01375, P49841, P48023, Q16718, O14521TNF, GSK3B, FASLG, NDUFA5, SDHDMore
Mesoridazinehsa04940Type I diabetes mellitus1.87E-022P48023, P01375FASLG, TNFMore
Mesoridazinehsa04961Endocrine and other factor-regulated calcium reabsorption2.68E-023P20020, Q9UEF7, P17252ATP2B1, KL, PRKCAMore
Mesoridazinehsa04970Salivary secretion1.91E-023P07550, P22694, P49913ADRB2, PRKACB, CAMPMore
Mesoridazinehsa04972Pancreatic secretion2.68E-023Q14643, P20020, P17252ITPR1, ATP2B1, PRKCAMore
Mesoridazinehsa04973Carbohydrate digestion and absorption1.29E-022O43451, P42338MGAM, PIK3CBMore
Mesoridazinehsa04976Bile secretion3.32E-022O43315, P08183AQP9, ABCB1More
Mesoridazinehsa05020Prion disease3.80E-024Q16718, O14521, P49841, Q16539NDUFA5, SDHD, GSK3B, MAPK14More
Mesoridazinehsa05022Pathways of neurodegeneration - multiple diseases1.24E-026P49841, Q16718, O14521, Q13561, Q16539, Q08752GSK3B, NDUFA5, SDHD, DCTN2, MAPK14, PPIDMore
Mesoridazinehsa05031Amphetamine addiction4.32E-023P22694, P18848, Q13547PRKACB, ATF4, HDAC1More
Mesoridazinehsa05034Alcoholism2.89E-034Q93077, P62807, O60814, P68431HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12More
Mesoridazinehsa05120Epithelial cell signaling in Helicobacter pylori infection5.40E-057Q16539, P09341, P19875, P19174, P25024, P25025, P07948MAPK14, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2, LYNMore
Mesoridazinehsa05132Salmonella infection4.62E-0311P51617, Q9UJU2, Q13546, Q13489, P10415, O75369, O60603, Q9BQS8, Q13561, Q13509, P68371IRAK1, LEF1, RIPK1, BIRC3, BCL2, FLNB, TLR2, FYCO1, DCTN2, TUBB3, TUBB2CMore
Mesoridazinehsa05133Pertussis2.95E-032P0DP23, P0C0L4CALM1, C4AMore
Mesoridazinehsa05134Legionellosis1.29E-024P11215, P11142, P09341, P19875ITGAM, HSPA8, CXCL1, CXCL2More
Mesoridazinehsa05135Yersinia infection2.59E-0310Q05397, P51812, P13612, P06239, Q16539, Q02750, P49841, Q96JJ3, P01730, P01732PTK2, RPS6KA3, ITGA4, LCK, MAPK14, MAP2K1, GSK3B, ELMO2, CD4, CD8AMore
Mesoridazinehsa05143African trypanosomiasis3.01E-034P01375, P69905, P68871, P48023TNF, HBA2, HBB, FASLGMore
Mesoridazinehsa05144Malaria1.91E-023P01375, P35443, P26718TNF, THBS4, KLRK1More
Mesoridazinehsa05146Amoebiasis2.05E-0511P09341, P19875, P14778, P27930, P01375, P42338, P11215, P05089, P30679, P22694, P12814CXCL1, CXCL2, IL1R1, IL1R2, TNF, PIK3CB, ITGAM, ARG1, GNA15, PRKACB, ACTN1More
Mesoridazinehsa05152Tuberculosis1.08E-028Q13488, P48382, P25208, O60603, P10415, P01568, Q9UDY8, P51617TCIRG1, RFX5, NFYB, TLR2, BCL2, IFNA21, MALT1, IRAK1More
Mesoridazinehsa05160Hepatitis C1.27E-024P60033, P49841, P01375, P48023CD81, GSK3B, TNF, FASLGMore
Mesoridazinehsa05163Human cytomegalovirus infection8.17E-039P63218, P50151, P49841, P14778, Q13651, P25025, Q16539, O00463, P30101GNG5, GNG10, GSK3B, IL1R1, IL10RA, CXCR2, MAPK14, TRAF5, PDIA3More
Mesoridazinehsa05167Kaposi sarcoma-associated herpesvirus infection3.96E-024P62879, P16298, Q02750, P0CG47GNB2, PPP3CB, MAP2K1, UBBMore
Mesoridazinehsa05169Epstein-Barr virus infection1.68E-0312P13765, Q13547, O00463, Q16539, P07948, P30101, Q13761, P24522, P29728, P07766, P09693, P20963HLA-DOB, HDAC1, TRAF5, MAPK14, LYN, PDIA3, RUNX3, GADD45A, OAS2, CD3E, CD3G, CD247More
Mesoridazinehsa05170Human immunodeficiency virus 1 infection2.65E-0319P62873, P63218, P50151, P17252, Q13546, O00463, P30101, Q14643, P01568, P01730, Q16539, P51617, O60603, Q13315, P07766, P09693, P20963, P10415, Q9Y6Q5GNB1, GNG5, GNG10, PRKCA, RIPK1, TRAF5, PDIA3, ITPR1, IFNA21, CD4, MAPK14, IRAK1, TLR2, ATM, CD3E, CD3G, CD247, BCL2, AP1M2More
Mesoridazinehsa05171Coronavirus disease - COVID-193.87E-045P62249, P40429, P27635, Q07020, P05386RPS16, RPL13A, RPL10, RPL18, RPLP1More
Mesoridazinehsa05202Transcriptional misregulation in cancer9.36E-0416Q12778, Q15532, Q13315, P14780, P14923, Q15744, Q16548, Q13489, Q13077, O15550, P35226, P05164, P12838, P08246, Q9C0K0, P24522FOXO1, SS18, ATM, MMP9, JUP, CEBPE, BCL2A1, BIRC3, TRAF1, UTX, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45AMore
Mesoridazinehsa05203Viral carcinogenesis4.85E-023Q15283, P62807, O60814RASA2, HIST1H2BC, H2BC12More
Mesoridazinehsa05204Chemical carcinogenesis1.09E-033P09211, P78417, P11712GSTP1, GSTO1, CYP2C9More
Mesoridazinehsa05205Proteoglycans in cancer2.02E-0312Q13009, Q14643, O75369, P14780, P17252, O60603, P01375, P23588, P04628, Q13635, P22694, P08962TIAM1, ITPR1, FLNB, MMP9, PRKCA, TLR2, TNF, EIF4B, WNT1, PTCH1, PRKACB, CD63More
Mesoridazinehsa05235PD-L1 expression and PD-1 checkpoint pathway in cancer2.65E-0510P42338, O95267, P19174, P07766, P20963, P09693, P06239, Q04759, Q16539, P01730PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, PRKCQ, MAPK14, CD4More
Mesoridazinehsa05321Inflammatory bowel disease1.19E-036P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21RMore
Mesoridazinehsa05322Systemic lupus erythematosus1.31E-045P09871, Q93077, P62807, O60814, P68431C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12More
Mesoridazinehsa05330Allograft rejection2.72E-022P48023, P01375FASLG, TNFMore
Mesoridazinehsa05332Graft-versus-host disease1.91E-056P13765, P48023, P10747, P01375, P26715, Q13241HLA-DOB, FASLG, CD28, TNF, KLRC1, KLRD1More
Mesoridazinehsa05340Primary immunodeficiency3.99E-024P01730, P01732, P07766, P06239CD4, CD8A, CD3E, LCKMore
Mesoridazinehsa05415Diabetic cardiomyopathy1.28E-024Q16718, O14521, Q16539, P49841NDUFA5, SDHD, MAPK14, GSK3BMore

Community members of Mesoridazine (SDC: 5.38)

UniProtACGene NameProtein NameReported/
Predicted
DisGeNETSPVSdrugabilitySHiSBiNSDisG
P14416DRD2D(2) dopamine receptorReported00.060410.47792.5081
P11169SLC2A3Solute carrier family 2, facilitated glucose transporter member 3Predicted00.13570.065800.1995
P09211GSTP1Glutathione SNonetransferase PPredicted00.32040.35230.45661.3213
P05164MPOMyeloperoxidasePredicted10.20350.53680.55021.7255
Q9UDY8MALT1MucosaNoneassociated lymphoid tissue lymphoma translocation protein 1Predicted10.05160.1470.55920.8789
P31645SLC6A4SodiumNonedependent serotonin transporterPredicted00.047710.02032.0442
P37840SNCAAlphaNonesynucleinPredicted10.08530.13240.33210.6395
P30531SLC6A1SodiumNone and chlorideNonedependent GABA transporter 1Predicted10.08890.52020.10471.1894
P30939HTR1F5Nonehydroxytryptamine receptor 1FPredicted00.000910.01982.0202
P11712CYP2C9Cytochrome P450 2C9Predicted10.010610.15242.1577
Q13133NR1H3Oxysterols receptor LXRNonealphaPredicted00.01620.4390.20861.0947
Q13547HDAC1Histone deacetylase 1Predicted00.044710.9863.0084
P09874PARP1Poly [ADPNoneribose] polymerase 1Predicted10.553610.44822.725
P00734F2ProthrombinPredicted10.09630.7070.49771.9598
Q6PCB7SLC27A1LongNonechain fatty acid transport protein 1Predicted00.29150.07680.09920.3985
P30939HTR1F5Nonehydroxytryptamine receptor 1FPredicted00.000910.01982.0202
P07550ADRB2BetaNone2 adrenergic receptorPredicted00.007110.22052.224
This pair is Reported in Drugbank.
Gene nameUniProt_IDBioactivityValue (nM)
DRD2P14416Ki4.3
DRD2P14416Ki18.86
DRD2P14416Ki19